what ticks off NR (non retail) .. is the fact that

what ticks off NR (non retail) .. is the fact that after 11 years of *effort* .. P2O (the company) still survives

P2O has options .. one of which came to pass (by NR there for years) with an oft touted competitor *recently*

this technology is in its ascent .. as has been noted by numerous entities

considering that PTOI (the stock) has spent most of the last 7 years (10c reset on 12.31.13) @ sub 10c .. with a total *volume* traded of below 300M (April 2009 thru November 2020) .. P2O's investors (not traders .. not a disgruntled fired ex employee .. not upside down NR trolls) >> long ago << made up their minds to see this through .. but what truly seems to *gall* NR (non retail) is P2O's I/O and NRs' *inability* to force P2O into toxic dilution ..

NRs' playbook re: OTC targets is to always work a cycle of money .. then when the kill order is given .. relentlessly brutalize/compress OTC targets' PPS .. this usually ensures that OTC targets' stock will be diluted .. and so the cycle continues ad nauseam

so yep .. it is crystal clear to those with functioning gray matter .. that PTOI's shares have been held by actual investors .. 1000s of them ..

P2O's first sale (funds' conveyed) removes the logjam ..

how *telling* the desperation revealed and ratcheted these days by non investors


hmmmm

4kids